The role of podoplanin inhibitors in controlling oral cancer progression
- 1 November 2023
- journal article
- research article
- Published by Elsevier in Archives of Oral Biology
- Vol. 157, 105841
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Higher Education, Malaysia (FRGS/1/2022/WAB13/UIAM/02/1)
This publication has 48 references indexed in Scilit:
- Plant Lectin Can Target Receptors Containing Sialic Acid, Exemplified by Podoplanin, to Inhibit Transformed Cell Growth and MigrationPLOS ONE, 2012
- Podoplanin: emerging functions in development, the immune system, and cancerFrontiers in Immunology, 2012
- Enhanced Expression of Podoplanin in Oral Carcinomas in situ and Squamous Cell CarcinomasPathobiology, 2011
- Deadly allies: the fatal interplay between platelets and metastasizing cancer cellsBlood, 2010
- Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlationsVirchows Archiv, 2010
- Podoplanin and ABCG2: Malignant Transformation Risk Markers for Oral Lichen PlanusCancer Epidemiology, Biomarkers & Prevention, 2010
- Characterization of Anti-podoplanin Monoclonal Antibodies: Critical Epitopes for Neutralizing the Interaction Between Podoplanin and CLEC-2Hybridoma, 2008
- Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domainBiochemical and Biophysical Research Communications, 2006
- Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transitionJournal of Cell Science, 2006
- Overexpression of podoplanin in oral cancer and its association with poor clinical outcomeCancer, 2006